Asset Management Corp’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$992K Buy
1,721
+174
+11% +$98.1K 0.78% 29
2022
Q4
$852K Buy
1,547
+1
+0.1% +$530 0.71% 34
2022
Q3
$784K Buy
1,546
+125
+9% +$70K 0.47% 44
2022
Q2
$772K Sell
1,421
-64
-4% -$35.2K 0.5% 45
2022
Q1
$877K Buy
1,485
+52
+4% +$29.9K 0.44% 52
2021
Q4
$956K Buy
1,433
+83
+6% +$51.8K 0.47% 56
2021
Q3
$771K Buy
1,350
+26
+2% +$14.3K 0.39% 67
2021
Q2
$668K Buy
1,324
+731
+123% +$345K 0.38% 63
2021
Q1
$271 Sell
593
-13
-2% -$6.21K 0.12% 146
2020
Q4
$305K Hold
606
0.17% 125
2020
Q3
$267K Buy
+606
New +$250K 0.16% 116

Other funds holding TMO

Asset Management Corp's TMO Position: Q1 2023 in Review

Asset Management Corp increased its Thermo Fisher Scientific (TMO) stake by 11% in Q1 2023, buying an estimated $98.1K and bringing the position to 1,721 shares worth $992K. The position accounts for 0.78% of the portfolio, ranked #29.

Asset Management Corp first reported a position in TMO in Q3 2020 and has held it in 11 quarters since. 2,386 funds tracked by Wall St. Rank hold TMO as of Q1 2023.

  • Asset Management Corp held 1,721 shares of Thermo Fisher Scientific worth $992K as of Q1 2023.
  • Asset Management Corp bought 174 Thermo Fisher Scientific shares in Q1 2023, an estimated $98.1K.
  • Thermo Fisher Scientific made up 0.78% of Asset Management Corp's portfolio in Q1 2023, its #29 holding.
  • Asset Management Corp first reported a position in Thermo Fisher Scientific in Q3 2020 and has held it in 11 quarters since.
  • 2,386 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2023.

Based on Asset Management Corp's 13F filing for Q1 2023, filed 14 Apr 2023.